RCBTB2

Chr 13

RCC1 and BTB domain containing protein 2

Also known as: CHC1L, RLG

The protein contains BTB/POZ domains and may function as a guanine nucleotide exchange factor involved in chromosome condensation regulation. Mutations cause autosomal recessive developmental and epileptic encephalopathy with severe intellectual disability and seizures beginning in infancy. The gene shows minimal constraint against loss-of-function variants, consistent with recessive inheritance where heterozygous carriers are typically unaffected.

Summary from RefSeq
Research Assistant →
0
Active trials
2
Pubs (1 yr)
63
P/LP submissions
0%
P/LP missense
0.94
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryRCBTB2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
63 unique Pathogenic / Likely Pathogenic· 72 VUS of 145 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.94LOEUF
pLI 0.000
Z-score 1.79
OE 0.64 (0.440.94)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.06Z-score
OE missense 1.01 (0.921.11)
313 obs / 310.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.64 (0.440.94)
00.351.4
Missense OE1.01 (0.921.11)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 18 / 28.2Missense obs/exp: 313 / 310.1Syn Z: 0.83
DN
0.7035th %ile
GOF
0.6833th %ile
LOF
0.3066th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

145 submitted variants in ClinVar

Classification Summary

Pathogenic61
Likely Pathogenic2
VUS72
61
Pathogenic
2
Likely Pathogenic
72
VUS

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
61
0
61
Likely Pathogenic
0
0
2
0
2
VUS
0
69
3
0
72
Likely Benign
0
0
0
0
0
Benign
0
0
0
0
0
Total069660135

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RCBTB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →